August 2015 Vol. 10 No. 8

FDA approves new drugs

On Sept. 2, the U.S. Food and Drug Administration (FDA) approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and…

ISMP releases IV push meds guidelines

The Institute for Safe Medication Practices (ISMP) has released new safe practice guidelines for adult IV push medications. Read more.

Neurocysticercosis: More than a headache

Neurocysticercosis, the most common parasitical infection of the central nervous system, is caused by accidental ingestion of eggs from Taenia…

Our Readers Respond

More about moral pitfalls “Conscience, legalism, and the clash of rights” provided an excellent discussion of some of the ethical…

Quiz time – August 2015

Which statement about shifts in the oxyhemoglobin dissociation curve is correct? a. With a shift to the right, hemoglobin releases…

Racial bias in health care

On Aug. 11, JAMA published “Racial Bias in Health Care and Health: Challenges and Opportunities.” Read the viewpoint.

Risk/benefit ratio for statins

A study in the American Journal of Physiology—Cell Physiology highlights the importance of weighing risk with benefits when considering statins…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.